NEIL BRICKEL: Open Payments
NPI 1396716981 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,836 in 139 payments from 16 companies in 2025. Trend: 2023 $3,410 · 2024 $2,517 · 2025 $2,836
Food & beverage: $2,836
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $510 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $415 |
| Corium, LLC | 21 | $388 |
| Otsuka America Pharmaceutical, Inc. | 15 | $339 |
| Axsome Therapeutics, Inc. | 10 | $267 |
| Lundbeck LLC | 9 | $241 |
| Neurocrine BioSciences, Inc. | 10 | $154 |
| Tris Pharma Inc | 11 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Alkermes, Inc. | 3 | $69 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Azstarys, Auvelity, INGREZZA, Dyanavel XR, TRINTELLIX.
Industry payments across MO — which companies pay providers there.
